Ceyla Ataç

Dr. Ceyla Ataç


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2016 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
CACeyla Ataç
Ceyla Ataç
BÇBurcu Gökçe Çokal
Burcu Gökçe Çokal
HAHanzade Aybüke Ünal Artık
Hanzade Aybüke Ünal Artık
LİLevent Ertuğrul İnan
Levent Ertuğrul İnan
TYTahir Kurtuluş Yoldaş
Tahir Kurtuluş Yoldaş

8 March 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
NÇNeşe Çelebisoy
Neşe Çelebisoy
AAAyşın Kısabay Ak
Ayşın Kısabay Ak
HÖHüseyin Nezih Özdemir
Hüseyin Nezih Özdemir
FGFigen Gökçay
Figen Gökçay
GDGülsüm Saruhan Durmaz
Gülsüm Saruhan Durmaz
FUFeray Güleç Uyaroğlu
Feray Güleç Uyaroğlu

12 April 2023 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
NÇNeşe Çelebisoy
Neşe Çelebisoy
AAAyşın Kısabay Ak
Ayşın Kısabay Ak
CACeyla Ataç
Ceyla Ataç
HÖHüseyin Nezih Özdemir
Hüseyin Nezih Özdemir
FGFigen Gökçay
Figen Gökçay
FUFeray Güleç Uyaroğlu
Feray Güleç Uyaroğlu

17 November 2020 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
CACeyla Ataç
Ceyla Ataç
AAAyşın Kısabay Ak
Ayşın Kısabay Ak
MBMelike Batum
Melike Batum
MAMehmet Semih Ari
Mehmet Semih Ari
GOGülgün Yılmaz Ovalı
Gülgün Yılmaz Ovalı
NÇNeşe Çelebisoy
Neşe Çelebisoy

31 December 2020 in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
PDF file
CACeyla Ataç
Ceyla Ataç
EEEzgi Tuna Erdoğan
Ezgi Tuna Erdoğan
Objective: The objective of our study was to investigate changes in pattern reversal visual evoked potentials (PVEPs) of migraine without aura patients recorded with two different check sizes (15’ and 62’) in accordance with International Society for Clinical Electrophysiology of Vision (ISCEV) standards during the interictal period. Materials and Methods: Patients' demographic data were documented from headache diaries of patients, such as duration of disease, headache characteristics, the number of attacks in a month, the average duration of attacks, complaints accompanying headache, mean severity of headache according to visual analog scale. Twenty migraine patients without aura and 14 healthy volunteers were examined with PVEPs recorded with two different check-sizes (15’ and 62’). The stimulation sequences were randomized both for the check-size of checkerboard and the side of stimulation (right-15', right-62', left-15', left-62'). The latency of N75, P100 and peak-to-peak amplitude of N75-P100 were analyzed. Results: There were no statistical difference between healthy subjects and migraine without aura patients in the means of latency and amplitude of PVEPs results for both check-sizes (p>0,05). Conclusion: In migraine patients without aura, we did not detect magnocellular pathway dysfunction by PVEPs with different spatial frequencies. Studies on larger patient groups and combining PVEPs with psychophysical tests are needed.

1 January 2017 in Ağrı - The Journal of The Turkish Society of Algology
Verified
Journal Article
Closed access
CACeyla Ataç
Ceyla Ataç
White matter hyperintensities (WMHs) are observed in patients with migraine with aura (MWA) and without aura (MWO), but there are a limited number of studies regarding patients with MWA. In this study, we aimed to investigate the cardiovascular risk factors which may play a role in the development of WMHs in patients with MWO. This observational, analytical, case-control study was conducted between June 2016 and January 2017. It included 21 patients with MWO who had WMHs on brain MRI and 19 patients with MWO who tested normal on MRI (control group) at the Neurology Department Outpatient Polyclinic, Ankara Training and Research Hospital. The patients' data (history, family history, neurological examination findings, echocardiography findings, and cerebral MRI findings) were retrospectively reviewed. Age, gender, body mass index, blood lipid level, migraine duration, localization of headache, average number of headache per month, medication for headache attack, and echocardiography findings were similar between the two groups. (p>0.05). In this study, we did not find any association between cardiovascular risk factors and WMHs development in patients with MWO. The association of risk factors other than cardiovascular risk factors (genetic factors and oxidative stress) with the development of WMHs in patients with MWO should also be studied in future.